Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00395603
(This study was terminated early due to poor recruitment.)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Greater than 18 years of age
Treated for at least the last 3 months with a daily dose of atorvastatin 40 mg
Existing coronary heart disease and cholesterol > 4.0 mmol/l
Elevated liver function tests
Elevated creatine kinase (ck)
Triglycerides (tg) > 4.5 mmol/l
Drug or alcohol dependency within 6 months prior to visit 1
Woman receiving hormonal therapy who have not been maintained on a stable dose and regimen for at least 8 weeks and are willing to continue the same regimen for the duration of the study
Woman of childbearing potential not using an acceptable method of birth control